Castle Biosciences

Nov 8, 2024 | markets.financialcontent.com | Castle Biosciences

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new data highlighting the clinical performance of its DecisionDx-Melanoma and MyPath Melanoma tests at the American Society of Dermatopathology (ASDP) 61st Annual Meeting, being held Nov. 7-10, in Chicago.

Nov 8, 2023 | money.mymotherlode.com | Castle Biosciences

IDgenetix is a clinically validated pharmacogenomic (PGx) test that incorporates drug-gene interactions, drug-drug interactions and lifestyle factors to guide medication management for patients’ neuropsychiatric conditions, such as depression and anxietyCastle Biosciences, Inc.

Sep 30, 2023 | advfn.com | Castle Biosciences

0001447362FALSE00014473622024-01-072024-01-07UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): January 7, 2024Castle Biosciences, Inc. (Exact name of registrant as specified in its charter)Delaware001-3898477-0701774(state or other jurisdictionof incorporation)(CommissionFile Number)(I.R.S. EmployerIdentification No.)505 S.

Sep 25, 2023 | money.mymotherlode.com | Castle Biosciences

Studies have shown that using Castle’s DecisionDx®-Melanoma test to help guide the care of patients with melanoma, the deadliest form of skin cancer, improves health outcomes1-5Castle’s management team will also ring the New York Stock Exchange closing bell on Sept. 28 as a member of the Texas Capital Texas Equity Index exchange traded fund (ETF)Castle Biosciences, Inc.

Jul 19, 2023 | app.researchpool.com | Castle Biosciences

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2023, after the close of market on Wednesday, Aug. 2, 2023. Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.